Delivery Order SPE2DB20D3104-SPE2DB25FV9A7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Voriconazole 200 mg tablets in quantities of 30 units, with a ceiling value of $4,455.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Voriconazole 200 mg tablets (30-count) with a ceiling value of $14,633.76. This firm fixed-price, competitively awarded contract was finalized on July 28, 2025, with an ultimate completion date of July 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order does not include a set-aside designation and represents a tactical...
- This delivery order for voriconazole 200 mg tablets was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp on October 5, 2023. The order has a potential value of $212 and requires delivery of the pharmaceutical products by October 6, 2023. This firm fixed price order was issued under an existing prime vendor contract vehicle and has no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen's corporate...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,730,842 vials of the pharmaceutical drug voriconazole 200 mg. The $2,445.98 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 28, 2024, with an ultimate completion date of May 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Voranigo 40 mg tablets (30-count units) with a ceiling value of $27,094.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- This federal contract award is for the delivery of voriconazole 200 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,540.80 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $54,419.28 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Voranigo 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9A7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,948.35 to AmerisourceBergen Drug Corp for the supply of Voriconazole 200 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This award represents a child contract, indicating it was issued under an existing contract vehicle rather than as a standalone prime contract. This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that supports pharmaceutical procurement across global military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor serving federal medical supply needs, has demonstrated capability to fulfill federal procurement requirements through competitive awards. The company's extensive federal contract portfolio includes delivery of diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/23/25 |